申请人:Ikeura Yoshinori
公开号:US20090186874A1
公开(公告)日:2009-07-23
The present invention relates to a compound represented by the formula
wherein ring A is a nitrogen-containing heterocycle optionally further having substituent(s), ring B and ring C are each an aromatic ring optionally having substituent(s), R
1
is a hydrogen atom, a hydrocarbon group optionally having substituent(s), an acyl group or a heterocyclic group optionally having substituent(s), Z is an optionally halogenated C
1-6
alkyl group, Y is a methylene group optionally having substituent(s), m and n are each an integer of 0 to 5, m+n is an integer of 2 to 5, and
is a single bond or a double bond, or a salt thereof. The compound of the present invention has a superior tachykinin receptor antagonistic action, particularly an SP receptor antagonistic action, and is useful as a pharmaceutical agent, for example, a tachykinin receptor antagonist, an agent for the prophylaxis or treatment of an abnormality of lower urinary tract functions, a digestive organ disease or a central nerve disease, and the like.
本发明涉及一种化合物,其表示为以下式子:
其中,环A是一种含氮杂环,可以选择进一步具有取代基;环B和环C分别是芳香环,可以选择进一步具有取代基;R1是氢原子,一个碳氢基团,可以选择进一步具有取代基,一个酰基基团或一个杂环基团,可以选择进一步具有取代基;Z是一个可选择卤代的C1-6烷基基团,Y是一个可选择具有取代基的亚甲基基团,m和n均为0到5的整数,m+n是2到5的整数,且是单键或双键,或其盐。本发明的化合物具有优异的速激肽受体拮抗作用,特别是SP受体拮抗作用,并且可用作制药剂,例如速激肽受体拮抗剂,预防或治疗下尿路功能异常、消化器官疾病或中枢神经疾病等。